検索結果

int research. Under this agreement, Alchemedicine will discover and optimize drug candidate for one target of interest in Senju Pharmaceutical. With a sense of mission to serve the eye health of peopl...

announce today that it has been applied for manufacturing and marketing approval in Japan. DED, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

, which has a novel mechanism of action, for the treatment of Dry Eye Disease. Dry Eye Disease, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

, which has a novel mechanism of action, for the treatment of Dry Eye Disease. Dry Eye Disease, the target disease of SJP-0132, is defined as “A multifactorial disease characterized by an unstable tea...

ound having the development code SJP-0008. Central Retinal Artery Occlusion (CRAO), the therapeutic target of SJP-0008, occurs when central retinal artery occlusion leads to irreversible impairment of...